Cargando…
Combined-modality therapy for pulmonary alveolar proteinosis in a remote setting: a case report
BACKGROUND: Pulmonary alveolar proteinosis (PAP) is a rare lung disease characterized by accumulation of phospholipoproteinaceous material in the alveoli. The presentation is nonspecific but typically includes dyspnea; the spectrum of disease includes rapidly progressive hypoxic respiratory failure....
Autores principales: | Boyce, Dacia S. K., Lee, John W., Shah, Phalgoon, Freeman, Judy H., Aboudara, Matthew C., Hostler, David C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417025/ https://www.ncbi.nlm.nih.gov/pubmed/30866900 http://dx.doi.org/10.1186/s12890-019-0822-x |
Ejemplares similares
-
Congenital Pulmonary Alveolar Proteinosis
por: Hammami, Saber, et al.
Publicado: (2013) -
Pulmonary alveolar proteinosis in children
por: Bush, Andrew, et al.
Publicado: (2020) -
COVID-19 and pulmonary alveolar proteinosis: an unusual combination
por: Colares, Philippe de Figueiredo Braga, et al.
Publicado: (2022) -
Pulmonary alveolar proteinosis: from classification to therapy
por: Salvaterra, Elena, et al.
Publicado: (2020) -
Prevalence and healthcare burden of pulmonary alveolar proteinosis
por: McCarthy, Cormac, et al.
Publicado: (2018)